| Product Code: ETC8889948 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Next Generation Cancer Diagnostics Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Next Generation Cancer Diagnostics Market - Industry Life Cycle |
3.4 Portugal Next Generation Cancer Diagnostics Market - Porter's Five Forces |
3.5 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Cancer, 2021 & 2031F |
3.8 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume Share, By Function, 2021 & 2031F |
4 Portugal Next Generation Cancer Diagnostics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer cases in Portugal |
4.2.2 Growing adoption of advanced diagnostic technologies |
4.2.3 Supportive government initiatives and funding for cancer research and diagnosis |
4.3 Market Restraints |
4.3.1 High cost associated with next generation cancer diagnostics |
4.3.2 Limited access to advanced diagnostic facilities in rural areas of Portugal |
5 Portugal Next Generation Cancer Diagnostics Market Trends |
6 Portugal Next Generation Cancer Diagnostics Market, By Types |
6.1 Portugal Next Generation Cancer Diagnostics Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By Next-generation Sequencing, 2021- 2031F |
6.1.4 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By qPCR & Multiplexing, 2021- 2031F |
6.1.5 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR), 2021- 2031F |
6.1.6 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By Protein Microarrays, 2021- 2031F |
6.1.7 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By DNA Microarrays, 2021- 2031F |
6.2 Portugal Next Generation Cancer Diagnostics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By Biomarker Development, 2021- 2031F |
6.2.3 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By CTC Analysis, 2021- 2031F |
6.2.4 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By Proteomic Analysis, 2021- 2031F |
6.2.5 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By Epigenetic Analysis, 2021- 2031F |
6.2.6 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By Genetic Analysis, 2021- 2031F |
6.3 Portugal Next Generation Cancer Diagnostics Market, By Cancer |
6.3.1 Overview and Analysis |
6.3.2 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.3.3 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.3.4 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.3.5 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.3.6 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Portugal Next Generation Cancer Diagnostics Market, By Function |
6.4.1 Overview and Analysis |
6.4.2 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By Therapeutic Monitoring, 2021- 2031F |
6.4.3 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F |
6.4.4 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By Prognostics, 2021- 2031F |
6.4.5 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By Cancer Screening, 2021- 2031F |
6.4.6 Portugal Next Generation Cancer Diagnostics Market Revenues & Volume, By Risk Analysis, 2021- 2031F |
7 Portugal Next Generation Cancer Diagnostics Market Import-Export Trade Statistics |
7.1 Portugal Next Generation Cancer Diagnostics Market Export to Major Countries |
7.2 Portugal Next Generation Cancer Diagnostics Market Imports from Major Countries |
8 Portugal Next Generation Cancer Diagnostics Market Key Performance Indicators |
8.1 Number of research grants received for cancer diagnostics development |
8.2 Adoption rate of next generation cancer diagnostic technologies in major healthcare facilities |
8.3 Number of collaborations between diagnostic companies and research institutions for advancing cancer diagnostics in Portugal |
9 Portugal Next Generation Cancer Diagnostics Market - Opportunity Assessment |
9.1 Portugal Next Generation Cancer Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Portugal Next Generation Cancer Diagnostics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Portugal Next Generation Cancer Diagnostics Market Opportunity Assessment, By Cancer, 2021 & 2031F |
9.4 Portugal Next Generation Cancer Diagnostics Market Opportunity Assessment, By Function, 2021 & 2031F |
10 Portugal Next Generation Cancer Diagnostics Market - Competitive Landscape |
10.1 Portugal Next Generation Cancer Diagnostics Market Revenue Share, By Companies, 2024 |
10.2 Portugal Next Generation Cancer Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here